These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 28392221)

  • 1. Melanoma-Derived iPCCs Show Differential Tumorigenicity and Therapy Response.
    Bernhardt M; Novak D; Assenov Y; Orouji E; Knappe N; Weina K; Reith M; Larribere L; Gebhardt C; Plass C; Umansky V; Utikal J
    Stem Cell Reports; 2017 May; 8(5):1379-1391. PubMed ID: 28392221
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Melanoma Progression Inhibits Pluripotency and Differentiation of Melanoma-Derived iPSCs Produces Cells with Neural-like Mixed Dysplastic Phenotype.
    Castro-Pérez E; Rodríguez CI; Mikheil D; Siddique S; McCarthy A; Newton MA; Setaluri V
    Stem Cell Reports; 2019 Jul; 13(1):177-192. PubMed ID: 31231022
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Divergent reprogramming routes lead to alternative stem-cell states.
    Tonge PD; Corso AJ; Monetti C; Hussein SM; Puri MC; Michael IP; Li M; Lee DS; Mar JC; Cloonan N; Wood DL; Gauthier ME; Korn O; Clancy JL; Preiss T; Grimmond SM; Shin JY; Seo JS; Wells CA; Rogers IM; Nagy A
    Nature; 2014 Dec; 516(7530):192-7. PubMed ID: 25503232
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term culture following ES-like gene-induced reprogramming elicits an aggressive phenotype in mutated cholangiocellular carcinoma cells.
    Nagai K; Ishii H; Miyoshi N; Hoshino H; Saito T; Sato T; Tomimaru Y; Kobayashi S; Nagano H; Sekimoto M; Doki Y; Mori M
    Biochem Biophys Res Commun; 2010 Apr; 395(2):258-63. PubMed ID: 20381452
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cell reprogramming into the pluripotent state using graphene based substrates.
    Yoo J; Kim J; Baek S; Park Y; Im H; Kim J
    Biomaterials; 2014 Sep; 35(29):8321-9. PubMed ID: 24996757
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-efficiency generation of induced pluripotent mesenchymal stem cells from human dermal fibroblasts using recombinant proteins.
    Chen F; Zhang G; Yu L; Feng Y; Li X; Zhang Z; Wang Y; Sun D; Pradhan S
    Stem Cell Res Ther; 2016 Jul; 7(1):99. PubMed ID: 27473118
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor-Free Transplantation of Patient-Derived Induced Pluripotent Stem Cell Progeny for Customized Islet Regeneration.
    El Khatib MM; Ohmine S; Jacobus EJ; Tonne JM; Morsy SG; Holditch SJ; Schreiber CA; Uetsuka K; Fusaki N; Wigle DA; Terzic A; Kudva YC; Ikeda Y
    Stem Cells Transl Med; 2016 May; 5(5):694-702. PubMed ID: 26987352
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Possible Strategies to Reduce the Tumorigenic Risk of Reprogrammed Normal and Cancer Cells.
    Lin YC; Ku CC; Wuputra K; Liu CJ; Wu DC; Satou M; Mitsui Y; Saito S; Yokoyama KK
    Int J Mol Sci; 2024 May; 25(10):. PubMed ID: 38791215
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Qualitative Analyses of Protein Phosphorylation in Bovine Pluripotent Stem Cells Generated from Embryonic Fibroblasts.
    Nong W; Xie TS; Li LY; Lu AG; Mo J; Gou YF; Lan G; Jiang H; Len J; Li MM; Jiang QY; Huang B
    Reprod Domest Anim; 2015 Dec; 50(6):989-98. PubMed ID: 26493745
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Derivation of human induced pluripotent stem cells through continued exposure of OCT4-induced plastic human fibroblasts to reprogramming media.
    Salci KR; Lee JB; Mitchell RR; Orlando L; Fiebig-Comyn A; Shapovalova Z; Bhatia M
    Stem Cell Res; 2015 Jul; 15(1):240-2. PubMed ID: 26141785
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reprogramming somatic cells into pluripotent stem cells using miRNAs.
    Anokye-Danso F
    Methods Mol Biol; 2014; 1150():273-81. PubMed ID: 24744006
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Robust Differentiation of mRNA-Reprogrammed Human Induced Pluripotent Stem Cells Toward a Retinal Lineage.
    Sridhar A; Ohlemacher SK; Langer KB; Meyer JS
    Stem Cells Transl Med; 2016 Apr; 5(4):417-26. PubMed ID: 26933039
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Cellular and molecular mechanisms of carcinogenic side effects and resistance to BRAF inhibitors in metastatic melanoma with BRAFV600 mutation: state of the knowledge].
    Capovilla M
    Ann Pathol; 2013 Dec; 33(6):375-85. PubMed ID: 24331719
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhanced Rejuvenation in Induced Pluripotent Stem Cell-Derived Neurons Compared with Directly Converted Neurons from an Aged Mouse.
    Yang Y; Jiao J; Gao R; Le R; Kou X; Zhao Y; Wang H; Gao S; Wang Y
    Stem Cells Dev; 2015 Dec; 24(23):2767-77. PubMed ID: 26192905
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differentiation and characterization of rhesus monkey atrial and ventricular cardiomyocytes from induced pluripotent stem cells.
    Zhang X; Cao H; Bai S; Huo W; Ma Y
    Stem Cell Res; 2017 Apr; 20():21-29. PubMed ID: 28249229
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acquisition of pluripotency through continued environmental influence on OCT4-induced plastic human fibroblasts.
    Salci KR; Lee JB; Mitchell RR; Orlando L; Fiebig-Comyn A; Shapovalova Z; Bhatia M
    Stem Cell Res; 2015 Jul; 15(1):221-30. PubMed ID: 26117529
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reprogramming cancer cells to pluripotency: an experimental tool for exploring cancer epigenetics.
    Stricker S; Pollard S
    Epigenetics; 2014 Jun; 9(6):798-802. PubMed ID: 24686321
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Generation and Neuronal Differentiation of Patient-Specific Induced Pluripotent Stem Cells Derived from Niemann-Pick Type C1 Fibroblasts.
    Trilck M; Hübner R; Frech MJ
    Methods Mol Biol; 2016; 1353():233-59. PubMed ID: 25520288
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of the early and late responder genes during the generation of induced pluripotent stem cells from mouse fibroblasts.
    Park J; Kwon YW; Ham S; Hong CP; Seo S; Choe MK; Shin SI; Lee CS; Kim HS; Roh TY
    PLoS One; 2017; 12(2):e0171300. PubMed ID: 28152015
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vemurafenib resistance reprograms melanoma cells towards glutamine dependence.
    Hernandez-Davies JE; Tran TQ; Reid MA; Rosales KR; Lowman XH; Pan M; Moriceau G; Yang Y; Wu J; Lo RS; Kong M
    J Transl Med; 2015 Jul; 13():210. PubMed ID: 26139106
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.